Pharmaceutical manufacturing business in India

id - 282
icon
India
Pharmaceuticals
Views: 200
  • Pharmaceutical manufacturing business in India
  • Pharmaceutical manufacturing business in India
    Pharmaceutical manufacturing business in India
  • Revenue (year) 25,000,000 $
    1,975,070,000 ₽
    Profit (year) 3,000,000 $
    237,008,400 ₽
    Payback (mon.)
    Description

    Pharmaceutical manufacturing business in India is for sale. The company was founded in the district Punjab, India, 1982 with a purpose of manufacturing active pharmaceutical ingredients. The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines. They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.

    The company is offerings range from antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.

    Research

    Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.

    Studies

    Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.

    Biotechnology

    The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.

    Team

    The team is composed by 100 enlightened individuals: chemists, pharmacists, biotechnologists, quality controllers, R&D experts, warehousing personnel.

    Keypoints

    • Market: 65% India / 35% rest of the world / Europe
    • Products: 25 OEM products / pharma active ingredients raw material
    • Most sold: antibiotics
    • Standards: ISO9001, EU Standards (No FDA)
    • Growth rate: 20%+ per year
    • Financial: $25M Revenue / $3M EBITDA

    To obtain the details, the potential buyer must sign the NDA and send the POF.

    The information in the catalog is not an exact offer. The parameters of the deal are specified during negotiations with the seller.

    To perform this action, you must log in or register on the site.
    Start negotiation
    Price
    40,000,000 $
    3,160,112,000 ₽
    To perform this action, you must log in or register on the site.
    Start negotiation
    icon Useful tip

    Want to compare several objects in the catalog to choose the best one? Add it to "Comparisons". To do this, click the scale icon in the upper right corner of the card or ad page. In each section of the catalog, you can create a comparison list of up to 5 lots.

    Similar adverts
    icon
    India
    Pharmaceutical company in India Pharmaceutical company in India
    Revenue (year)
    306,500,000 $
    24,163,050,101 ₽
    Profit (year)
    87,500,000 $
    6,898,097,501 ₽
    Payback (mon.)
    Price
    1,050,000,000 $
    82,777,170,000 ₽
    icon
    Kyrgyzstan
    Medicine production plant in Kyrgyzstan Medicine production plant in Kyrgyzstan
    Audit done
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    6,000,000 €
    558,061,800 ₽
    icon
    Kazakhstan
    Pharmaceutical production in western Kazakhstan Pharmaceutical production in western Kazakhstan
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    3,000,000,000 ₸
    455,196,000 ₽
    Currency rates calculator
    Contact REAB
    Contact REAB
    Messengers for this number